Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emerging Data from a Newborn Hearing Screening Program in Sharjah, United Arab Emirates.

International journal of pediatrics·2021

Same author

Knowledge and Attitudes of Parents towards Childhood Hearing Loss and Pediatric Hearing Services in Sharjah, United Arab Emirates.

International journal of environmental research and public health·2021

Same author

Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance.

Human vaccines & immunotherapeutics·2014

Same author

Is sildenafil an effective therapy in the management of persistent pulmonary hypertension?

Journal of clinical neonatology·2013

Same author

Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.

American journal of perinatology·2008

Same author

Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?

Journal of perinatology : official journal of the California Perinatal Association·2005

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Intravenous Injections in Neonatal Mice

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Nonoliguric hyperkalemia in neonates: a case-controlled study.

¹Al Qassimi Hospital, Sharjah, United Arab Emirates. hakamyas@yahoo.com

American Journal of Perinatology

|November 26, 2008

Summary

Nonoliguric hyperkalemia (NOHK) significantly impacts preterm infants, leading to electrolyte imbalances, cardiac issues, and increased mortality. Early identification and management are crucial for affected neonates.

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jun 27, 2026

Intravenous Injections in Neonatal Mice

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Area of Science:

Neonatalogy
Pediatric Nephrology
Clinical Chemistry

Background:

Nonoliguric hyperkalemia (NOHK) is a critical condition in neonates.
Understanding its incidence, risk factors, and associated morbidities is vital for improving outcomes.

Purpose of the Study:

To determine the incidence, risk factors, and morbidities of NOHK in neonates.
To identify associations between NOHK and clinical/biochemical parameters.

Main Methods:

Prospective study comparing neonates with NOHK to controls.
NOHK defined by serum potassium (SK) > or = 7 mmol/L and urinary output > or = 1 mL/kg/h within 72 hours.
Monitoring of fluid intake, urinary output, and SK levels.

Main Results:

NOHK prevalence was 24% in extremely-low-birth-weight infants (<1000g).
Associated factors included fetal distress, metabolic acidosis, hyperglycemia, and lack of antenatal steroids.
NOHK infants showed electrolyte disturbances, higher urea/creatinine, and increased risk of cardiac arrhythmia (13%) and mortality (17%).

Conclusions:

NOHK predominantly affects preterm infants, often linked to specific risk factors.
Associated electrolyte imbalances and renal function markers require close monitoring.
NOHK poses significant risks, including cardiac arrhythmias and mortality, necessitating prompt clinical attention.